These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3696300)

  • 1. Possible prognostic significance of the assessment of dipeptidylpeptidase II in peripheral blood lymphocytes of patients with chronic lymphocytic leukemia.
    Klener P; Lojda Z; Háber J; Kvasnicka J
    Neoplasma; 1987; 34(5):581-6. PubMed ID: 3696300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidyl peptidases of human lymphocytes.
    Lojda Z
    Czech Med; 1988; 11(4):181-94. PubMed ID: 2905980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problems with prognostic criteria in patients with chronic lymphocytic leukemia with special reference to DPP II assessment.
    Klener P; Lojda Z; Háber J; Kvasnicka J; Cmunt E
    Neoplasma; 1985; 32(6):737-40. PubMed ID: 4088393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histochemical and immunocytochemical localization of dipeptidyl peptidases II and IV in human gingiva.
    Kennett CN; Cox SW; Eley BM
    J Periodontol; 1996 Sep; 67(9):846-52. PubMed ID: 8884640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on dipeptidylpeptidase II (DPP II).
    Gossrau R; Lojda Z
    Histochemistry; 1980; 70(1):53-76. PubMed ID: 7007298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleoli in peripheral blood lymphocytes of patients with chronic lymphocytic leukemia treated with cytostatic drugs.
    Kopeć J; Sitarska E; Leszko B
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):481-7. PubMed ID: 6670918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the prognostic role of cytogenetic, phenotypic, morphologic, and immune function characteristics in chronic lymphocytic leukemia.
    Rai KR; Sawitsky A
    Blood Cells; 1987; 12(2):327-38. PubMed ID: 3304471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlations between lymphocyte subpopulation and stage of disease in chronic lymphatic leukemia of Rai].
    Heilmann E; Nordiek R
    Haematologia (Budap); 1977; 11(3-4):289-95. PubMed ID: 311309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histochemical and biochemical studies of dipeptidyl peptidase I (DPP I) in laboratory rodents.
    Gossrau R
    Acta Histochem; 1991; 91(1):85-100. PubMed ID: 1801517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro metabolic degradation of a bovine growth hormone-releasing factor analog Leu27-bGRF(1-29)NH2 in bovine and porcine plasma. Correlation with plasma dipeptidylpeptidase activity.
    Kubiak TM; Kelly CR; Krabill LF
    Drug Metab Dispos; 1989; 17(4):393-7. PubMed ID: 2571478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imbalance of T cell subpopulations in patients with chronic lymphocytic leukaemia of the B cell type.
    Herrmann F; Lochner A; Philippen H; Jauer B; Rühl H
    Clin Exp Immunol; 1982 Jul; 49(1):157-62. PubMed ID: 6982129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte doubling time in chronic lymphocytic leukemia: an update of its prognostic significance.
    Viñolas N; Reverter JC; Urbano-Ispizua A; Montserrat E; Rozman C
    Blood Cells; 1987; 12(2):457-70. PubMed ID: 3620708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity of monoclonal antibodies OK-CLL (anti-CD5) with peripheral blood cells of patients with B cell lymphoproliferative disorders.
    Milosević D; Marinković M; Jelić S; Colović M; Spuzić I
    Arch Immunol Ther Exp (Warsz); 1995; 43(1):23-9. PubMed ID: 8744680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new parameter for chronic lymphocytic leukemia : determination of the large lymphocytes by means of Hemalog D (author's transl)].
    Vaugier G; Dighiero G; Charron D; Natali JC; Leporrier M; Debré P; d'Athis P; Binet JL
    Nouv Rev Fr Hematol (1978); 1978 Jun; 20(2):311-5. PubMed ID: 704345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognosis of chronic lymphatic leukemia. Retrospective study of the survival period 47 patients].
    Scolozzi R; Boccafogli A; Romanini D; Ramazzina E; Careri C; Guidoboni CA
    Minerva Med; 1981 Feb; 72(4-5):205-11. PubMed ID: 7207844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis in B-CLL: the relationship between higher ex vivo spontaneous apoptosis before treatment in III-IV Rai stage patients and poor outcome.
    Sieklucka M; Pozarowski P; Bojarska-Junak A; Hus I; Dmoszynska A; Rolinski J
    Oncol Rep; 2008 Jun; 19(6):1611-20. PubMed ID: 18497973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosomal dipeptidyl-peptidases I and II in human squamous cell lung carcinoma and lung parenchyma.
    Krepela E; Procházka J; Mynaríková H; Kárová B; Cermák J; Roubková H
    Neoplasma; 1996; 43(3):171-8. PubMed ID: 8841504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of cytoplasmic and nuclear shape of lymphocytes during progression of chronic lymphocytic leukemia.
    Sawicki W; Strojny P; Rozycka M; Traczyk Z; Polkowska E
    Anal Cell Pathol; 1989 Aug; 1(4):235-46. PubMed ID: 2487048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.